F18.280 Inhalant dependence with inhalant-induced anxiety disorder

Name of the Condition

• Common Name: Inhalant Dependence with Inhalant-Induced Anxiety Disorder
• Medical Term: Inhalant Dependence with Inhalant-Induced Anxiety Disorder

Summary

Inhalant dependence with inhalant-induced anxiety disorder is a substance use disorder characterized by a problematic pattern of inhalant use leading to clinically significant impairment or distress, accompanied by anxiety symptoms directly caused by inhalant use. It involves physiological, behavioral, and cognitive symptoms related to continued use despite adverse consequences, including tolerance, withdrawal, and compulsive use. The condition also includes anxiety symptoms (e.g., excessive worry, panic, or fear) that are attributable to the toxic effects of inhalants on the central nervous system, impacting physical health, mental functioning, and daily life.

Causes

Inhalant dependence with inhalant-induced anxiety disorder develops from repeated misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects. Inhalants are often common household or industrial products, such as glue, paint thinners, aerosols, or solvents. Prolonged use can alter brain chemistry, leading to dependence and related health issues. The anxiety symptoms arise from the toxic effects of these substances on the central nervous system, which may disrupt neurotransmitter balance and trigger anxiety responses.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.
• Withdrawal symptoms when use is reduced or stopped.
• Excessive worry, panic attacks, or fear unrelated to external stressors.
• Physical symptoms of anxiety (e.g., rapid heartbeat, shortness of breath).

Diagnosis

Diagnosis involves a comprehensive evaluation of the patient’s inhalant use history, behavioral patterns, and physical/mental health symptoms. Clinicians assess for a problematic pattern of use leading to impairment, along with anxiety symptoms that are temporally linked to inhalant exposure. Laboratory tests may rule out other causes of anxiety, and diagnostic criteria for inhalant dependence and inhalant-induced anxiety disorder are applied. A detailed history of substance use, including frequency, duration, and type of inhalants, is critical for accurate diagnosis.

Treatment Options

Treatment typically includes a combination of behavioral therapies (e.g., cognitive-behavioral therapy) to address dependence and anxiety, along with pharmacological interventions to manage withdrawal or anxiety symptoms. Supportive care, such as detoxification, may be necessary for severe cases. Long-term treatment focuses on relapse prevention and addressing underlying mental health needs. Family or group therapy can also support recovery.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence, duration of use, and response to treatment. Early intervention improves outcomes, but relapse is common without ongoing support. Follow-up care involves regular monitoring of inhalant use, anxiety symptoms, and overall mental health. Long-term management may include continued therapy and, in some cases, medication to stabilize mood or anxiety.

Complications

• Worsening anxiety or panic disorders.
• Cognitive decline or neurological damage.
• Organ damage (e.g., liver, kidney, or respiratory issues).
• Social or occupational impairment.
• Increased risk of accidental injury or overdose.

Lifestyle & Prevention

• Avoid exposure to inhalant products, especially in unsupervised settings.
• Educate at-risk populations (e.g., adolescents) about the dangers of inhalant use.
• Promote healthy coping mechanisms for stress or anxiety.
• Ensure proper storage and disposal of household chemicals.
• Seek early intervention for substance use concerns.

When to Seek Professional Help

Seek help if inhalant use is causing distress, impairment, or anxiety symptoms that interfere with daily life. Signs include inability to stop use, withdrawal symptoms, or persistent anxiety. Immediate care is needed for severe symptoms (e.g., overdose, respiratory distress) or suicidal thoughts.

Tips for Medical Coders

Document the presence of inhalant dependence and inhalant-induced anxiety disorder clearly in the medical record. Ensure the anxiety symptoms are directly attributable to inhalant use and not due to another condition. Include details on the pattern of use, duration, and impact on functioning to support code assignment. Verify that the diagnosis aligns with clinical criteria for both dependence and the induced anxiety disorder.